Company Overview of Blueprint Medicines Corporation
Daniel S. Lynch M.B.A.
Executive Chairman, Blueprint Medicines Corporation
|Age||Total Calculated Compensation||This person is connected to 7 Board Members in 7 different organizations across 13 different industries.|
See Board Relationships
38 Sidney StreetPhone: 617-374-7580
Cambridge, Massachusetts 02139
Board Members Memberships
Chief Executive Officer, President and Director
Director, Member of Audit Committee and Director of US Oncology Inc
Chairman, Chairperson of Compensation Committee and Member of Audit Committee
Chairman of the Board, Chairman of Compensation Committee, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
Colgate W. Darden Graduate School of Business Administration
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.